Skip to content

Effect of comprehensive lymphatic drainage on prevention of deep vein thrombosis after anterior cruciate ligament reconstruction

Effect of comprehensive lymphatic drainage on prevention of deep vein thrombosis after anterior cruciate ligament reconstruction

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300068740
Enrollment
Unknown
Registered
2023-02-28
Start date
2023-03-01
Completion date
Unknown
Last updated
2023-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

anterior cruciate ligament reconstruction

Interventions

experimental group: comprehensive lymphatic drainage
Control group:Intermittent pneumatic compression pump therapy

Sponsors

Peking University Shenzhen Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1) patients undergoing anterior cruciate ligament reconstruction; 2) age of 18-60 years old (according to the age of anterior cruciate ligament surgery indication); 3) negative preoperative DVT screening; 4) subjects voluntarily participated in the study and signed informed consent.

Exclusion criteria

Exclusion criteria: 1) patients who could not receive intervention within 6 hours after surgery; 2) Contraindications of comprehensive lymphatic drainage therapy: decompensated heart failure, cardiogenic edema, congestive heart failure, acute inflammation caused by bacteria/viruses/fungi, deep venous thrombosis of lower extremities, acute renal failure, acute venous disease; 3) Contraindications of intermittent pressure pump: lower extremity arterial disease, severe neuropathy, severe leg deformity, large area of leg edema, local skin or soft tissue lesions, limb gangrene; 4) patients combined with other ligament injuries; 5) the patient underwent unconventional ACL reconstruction (artificial ligament) if any other surgical procedure resulted in a postoperative rehabilitation protocol inconsistent with the traditional ACL surgery.

Design outcomes

Primary

MeasureTime frame
The incidence of VTE;

Secondary

MeasureTime frame
Blood flow velocity of femoral vein and great saphenous vein of lower extremity;pain score of VAS;Lysholm knee function score;

Countries

China

Contacts

Public ContactRen Yuxiang

Peking University Shenzhen Hospital

renyuxiang1101@163.com13500053132

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026